News | Artificial Intelligence | February 14, 2023

DiA Imaging Analysis’s LVivo IQS - a vendor-neutral AI-powered software solution - provides cardiac ultrasound users with real-time image quality feedback while scanning 

Radiology, the flagship journal of the Radiological Society of North America (RSNA), and the leading journal in the field of medical imaging, will feature special centennial content this year in connection with the publication’s 100th anniversary.

February 14, 2023 —DiA Imaging Analysis, a leading provider of advanced AI-based software solutions for ultrasound image analysis, announced today that the U.S. Food and Drug Administration (FDA) has cleared LVivo IQS, a new AI-based vendor-neutral software solution that enables ultrasound users to acquire high-quality interpretable cardiac ultrasound images that can be used to make better clinical assessments of the heart. 

High-quality cardiac ultrasound image acquisition can be challenging due to the constant motion of the heart and its deep location in the chest, as well as the user expertise that varies between ultrasound users and settings. 

DiA’s new LVivo IQS - Image Quality Score provides real-time image quality feedback while scanning the left ventricle of the heart to assess the heart’s performance. The software uses colors and numerical scoring to indicate the quality level of the image as it is being scanned, helping users to produce optimal interpretable images for more accurate and reproducible analysis of the heart. 

“LVivo IQS is the first of DiA’s 9 FDA-approved software solutions that empowers healthcare professionals with real-time feedback to enable the capture of high-quality ultrasound images,” said Hila Goldman-Aslan, CEO & Founder of DiA Imaging Analysis, “By harnessing the power of AI, our full suite of software solutions helps ultrasound users overcome two major challenges in the field – scanning high-quality images and accurately analyzing them. This holistic approach aligns with our mission of leveraging AI to make ultrasound image capture and analysis processes smarter and more accessible." 

The FDA cleared LVivo IQS following a clinical study that demonstrated its safety and efficacy. The results demonstrated high agreement between the LVivo IQS AI’s quality score feedback and the ability to obtain clinically interpretable images as evaluated by Cardiologist specializing in echocardiography. 91% of images saved by point-of-care residents using LVivo IQS, were found to be clinically interpretable images by the Cardiologist. 

“For precise heart diagnosis and treatment, high-quality cardiac ultrasound imaging is necessary in both point-of-care and other settings," said Dr. Lior Fuchs, Senior Intensive Care Physician at Soroka Medical Center in Israel and principal investigator of the LVivo IQS study.  

"LVivo IQS AI software will assist us in obtaining faster and clearer images to aid our real-time clinical decision-making process.” 


For more information: https://www.dia-analysis.com/ 

Find more ACC23 content here 


Related Content

News | Computed Tomography (CT)

March 31, 2023 — Philips, a global leader in health technology, and Connally Memorial Medical Center (CMMC), today ...

Time March 31, 2023
arrow
News | Enterprise Imaging

March 30, 2023 — Hyland Healthcare, whose solutions are used by more than half of the hospitals in the United States ...

Time March 30, 2023
arrow
News | HIMSS

March 29, 2023 — Over 2,000 leading executives have committed to attend HIMSS Global Health Conference & Exhibition, now ...

Time March 29, 2023
arrow
News | Artificial Intelligence

March 29, 2023 — In a partnership which aims to provide faster and safer medical imaging across Australia and New ...

Time March 29, 2023
arrow
News | Information Technology

March 27, 2023 — Royal Philips, a global leader in health technology, today announced the debut of Philips Virtual Care ...

Time March 27, 2023
arrow
News | Artificial Intelligence

March 27, 2023 — DeepTek.ai, a leading radiology AI company offering multiple AI-powered solutions for radiology ...

Time March 27, 2023
arrow
News | Breast Imaging

March 23, 2023 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

Time March 24, 2023
arrow
Feature | AIMed | By Melinda Taschetta-Millane

The 2023 AiMed Global Summit will focus on artificial intelligence (AI) in healthcare, and will offer valuable insights ...

Time March 23, 2023
arrow
News | Enterprise Imaging

March 22, 2023 — International medical imaging IT and cybersecurity company Sectra has signed a ten-year renewal ...

Time March 22, 2023
arrow
News | Lung Imaging

March 22, 2023 — The Riverain Technologies ClearRead Bone Suppression solution is now available on the Siemens ...

Time March 22, 2023
arrow
Subscribe Now